Edward Morrow Atkinson III, EVP, Chief Technical Operations Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,402 shares at $421.77 ($1.0M) on 2024-02-21, disclosed to the SEC on 2024-02-23.
Scheduled sale ($1.0M) by EVP, Chief Technical Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $421.77 | 1,201 | $507K | 50.0% |
| 2 | $421.77 | 1,201 | $507K | 50.0% |
| Total | $421.77 avg | 2,402 | $1.0M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-12 | $806K | — | Filing → |
| VRTX | SELL | 2025-11-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $1.3M | — | Filing → |